It was reported on May 10 that Sim High Technology (Jiangsu) Co., Ltd. (hereinafter referred to as Sim Medical), which focuses on the research and development of intraoperative imaging technology, recently completed a series A financing of tens of millions of RMB. This round of financing was led by a sub-fund of Nanjing Dynamic Balance Investment Management Co., Ltd. This round of financing aims to continue to increase investment in research and development, promote the development and registration of various products of Sim Medical, and accelerate the launch of its overall solution for intraoperative imaging; at the same time, Sim Medical stated that the funds will be used to expand the scale of production and further shorten the Product delivery time.
Sim Medical is a provider of intraoperative imaging solutions dedicated to advancing minimally invasive treatment of orthopedic surgery. Previously, it received a Pre-A round of tens of millions of financing in 2019. What made Sim Medical gain the favor of investors today, and once again won tens of millions of financing? We may be able to start from several dimensions such as the market where Sim Medical is located, the track and its own strength.
Investment Community Yiou Investment China Network
This article is reprinted from: https://readhub.cn/topic/8fTAxFsQBCD
This site is for inclusion only, and the copyright belongs to the original author.